FMS News Alert Fresenius Medical Care Corp (FMS) 37.40 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fresenius Medical Care Corp (FMS) 37.40 $FMS

Nxstage Medical's Home Dialysis System Gets FDA Go-Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 11:50AM CST
Nxstage Medical, Inc.'s (NXTM) System One is cleared by the FDA to perform hemodialysis overnight while the patient is at home, making it the first and only hemodialysis machine cleared for this indication.
ICUI: 83.38 (+1.63), NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), FMS: 37.40 (+0.15)

DaVita Healthcare's Outlook For 2015: Don't Overstay The Festivities
Cheryl Swanson - at Seeking Alpha - Fri Dec 19, 7:16AM CST

DVA: 76.06 (+0.07), FMS: 37.40 (+0.15), BRK.B: 151.54 (-0.21), BRK.A: 226,515.00 (-1,115.00)

Fresenius Medical Care's Emergency Response Plans Ensure Access to Dialysis Treatments Even When Winter's at its Worst
Business Wire - Mon Dec 15, 9:05AM CST
Weather forecasters aren't expecting another "Polar Vortex" to create widespread sub-zero temperatures across the United States this winter. But they are expecting a weak "El Nino" ocean-warming pattern over the eastern Pacific Ocean to contribute to above-average precipitation across the southern and eastern states, as well as colder-than average temperatures along the eastern seaboard and Gulf Coast.
FMS: 37.40 (+0.15)

The 1 Stock in Warren Buffett's Stocking This Holiday Season
Motley Fool Staff, Dan Dzombak, Eric Volkman, and Leo Sun - Motley Fool - Sun Dec 14, 8:04AM CST
Source: Warren Buffett via The Motley Fool. One way investors can find potential market-beating investments for the long term is to follow in the footsteps of successful billionaire investors, and there's no one more successful at investing for the...
T: 33.96 (-0.07), DVA: 76.06 (+0.07), DTV: 86.82 (-0.05), GM: 33.43 (-0.13), FMS: 37.40 (+0.15)

Merck-Cubist Deal Is On Despite Patent Setback
at Investor's Business Daily - Tue Dec 09, 10:27AM CST
Big pharma Merck affirmed Tuesday that it's going ahead with its $9.5 billion acquisition of biotech Cubist Pharmaceuticals even though Cubist's lead drug looks to face generic competition sooner than expected. Merck (MRK) stock was down 4.5% in...
CBST: 100.29 (-0.09), MRK: 57.46 (+0.25), MYL: 56.97 (+0.39), FMS: 37.40 (+0.15), TEVA: 57.09 (+0.33), HSP: 62.60 (-0.07)

Acadia Healthcare Grows Into Big Mental Health Player
at Investor's Business Daily - Mon Dec 08, 4:05PM CST
Not that long ago, IBD Leaderboard company Acadia Healthcare was a small player in behavioral health, with only a handful of facilities in the U.S. Then a new management team arrived on the scene with aggressive expansion in mind. Acadia's (ACHC) new...
ACHC: 62.92 (+0.34), DVA: 76.06 (+0.07), UHS: 111.87 (+0.99), FMS: 37.40 (+0.15), MD: 66.81 (+0.17)

Fresenius Medical (FMS) Scales 52-Week High on Strong Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 9:00AM CST
Shares of Fresenius Medical Care AG & Co. KGAA (FMS) reached a 52-week high of $37.20 on Nov 26, 2014.
FLDM: 32.31 (+0.30), EW: 130.75 (+1.17), FMS: 37.40 (+0.15), ANGO: 19.19 (+0.33)

Chef Aaron McCargo Jr. and Fresenius Medical Care Suggest Five Diabetes And Dialysis-Friendly Holiday Dishes the Whole Family Can Enjoy
Business Wire - Tue Nov 25, 10:48AM CST
Planning a holiday meal that everyone can enjoy takes special effort when guests or family members are among the 430,000 Americans with kidney failure who depend on dialysis. Their diets require lots of high-protein foods, while limiting their consumption of foods containing sodium, potassium and phosphorus. In addition, many people with kidney failure also have diabetes, and their need to additionally control carbohydrate intake can make meal planning even more complicated.
FMS: 37.40 (+0.15)

Is It Time To Shift Into European Equities?
Investment Biker - at Seeking Alpha - Sat Nov 22, 4:47AM CST

SNN: 38.18 (+0.14), SYT: 65.23 (-0.07), SHPG: 209.29 (+0.07), AZN: 70.44 (+0.26), FMS: 37.40 (+0.15), GRFS: 34.26 (+0.33), AEG: 7.63 (-0.04)

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 5:30PM CST
Medical device company, NxStage Medical Inc. (NXTM), recently launched Streamline Express, a gamma sterilized dialyzer for the in-center hemodialysis market.
NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), FMS: 37.40 (+0.15), RMTI: 8.41 (-0.07)

What Does The U.S. Dollar Bull Market Mean For European Equities?
Investment Biker - at Seeking Alpha - Thu Nov 20, 11:38AM CST

SNN: 38.18 (+0.14), SYT: 65.23 (-0.07), SHPG: 209.29 (+0.07), AZN: 70.44 (+0.26), FMS: 37.40 (+0.15), GRFS: 34.26 (+0.33), AEG: 7.63 (-0.04)

Fresenius bids for Danone med nutrition business
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:11AM CST

FMS: 37.40 (+0.15)

What The U.S. Dollar Bull Market Mean For The Global Equity Markets?
Investment Biker - at Seeking Alpha - Wed Nov 19, 9:25AM CST

SNN: 38.18 (+0.14), SPY: 207.77 (+0.02), SHPG: 209.29 (+0.07), AZN: 70.44 (+0.26), FMS: 37.40 (+0.15), GRFS: 34.26 (+0.33)

Fresenius buys specialist physicians group
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:53AM CST

FMS: 37.40 (+0.15)

Fresenius Medical Care to Present Extensive Research at the American Society of Nephrology's Kidney Week 2014 Conference
Business Wire - Tue Nov 11, 8:00AM CST
Fresenius Medical Care North America (FMCNA), the continent's leading provider of kidney care products and services, announced today that it will be presenting a broad array of clinical research at this year's American Society of Nephrology (ASN) Kidney Week 2014 conference.
FMS: 37.40 (+0.15)

Fresenius Medical Care Social Worker to Receive the 2014 Eleanor Clark Award for Innovative Patient Care
Business Wire - Thu Nov 06, 9:11AM CST
Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, announced today that Stephanie Johnstone, who has pioneered numerous innovations in nephrology social work during her 31 years with the company, has been selected to receive the 2014 Eleanor Clark Award for Innovative Patient Care from the Society for Social Work Leadership in Health Care (SSWLHC).
FMS: 37.40 (+0.15)

Fresenius Medical Care AG & Co. KGAA's (FMS) CEO Robert Powell on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 7:10PM CST

FMS: 37.40 (+0.15)

Fresenius Medical Care misses by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:16AM CST

FMS: 37.40 (+0.15)

Fresenius Medical Care Urges At-Risk Populations to Get Annual Flu Shots, And Shares Four Simple Truths About the Vaccine
Business Wire - Mon Nov 03, 11:03AM CST
Worldwide news broadcasts and headlines are filled these days with reports of the deadly Ebola virus. Yet most Americans are far more likely to be affected by the common seasonal flu, a contagious respiratory illness carried by airborne viruses and spread by sneezing and coughing, which each year infects millions of people in this country and causes more than 200,000 to be hospitalized.
FMS: 37.40 (+0.15)

Fresenius closes debt offering
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 11:08AM CDT

FMS: 37.40 (+0.15)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 90

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 34

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 112

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Crypto: Brian Armstrong on Innovative Payment Solutions

Updated Category News Views 292

Coinbase's Vision for Payments in the Crypto World Brian Armstrong, the CEO of Coinbase Global Inc. (NASDAQ: COIN), is optimistic about the role of payments as a transformative use case within the cryptocurrency landscape. In a recent discussion, he articulated how he believes this sector will significantly evolve, particularly in terms of integrating stablecoins into...

Continue Reading
Veeva Basics Empowering Biotechs to Enhance Efficiency and Growth

Updated Category News Views 185

Veeva Basics Revolutionizes Biotech Operations In today's fast-paced biotech landscape, efficient operations are crucial. Veeva Systems (NYSE: VEEV) has introduced Veeva Basics, a solution now adopted by over 100 emerging biotechs. With this innovative approach, these companies can simplify and standardize their operations, allowing them to focus on what truly matters:...

Continue Reading
Exploring the Rise of Small-Cap Stocks: A 2024 Overview

Updated Category News Views 613

Small-Cap Stocks Lead 2024 Gains In the vibrant market of 2024, small-cap stocks have shined brighter than ever, showcasing remarkable performance that has left traditional blue-chip stocks in their wake. While larger, well-known companies often dominate discussions, smaller firms are making headlines with exhilarating returns. Remarkable Returns in the Market This year,...

Continue Reading
Ridge Street Capital Signs Significant Growth in Lending Sector

Updated Category News Views 206

Ridge Street Capital's Impressive Growth in Investment Lending Ridge Street Capital, a dynamic private lending firm, is celebrating a remarkable achievement in its operation, reporting over 150% growth from one year to the next. This impressive advancement marks the firm as a key player in investment property financing, primarily due to its tailored approach and...

Continue Reading
Kuehn Law Advocates for Sarepta Therapeutics Shareholders

Updated Category News Views 153

Kuehn Law Advocates for Sarepta Therapeutics Shareholders Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is reaching out to investors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) regarding pressing concerns that have surfaced about the company's internal practices. Recent investigations suggest that certain officers and directors possibly did not uphold...

Continue Reading